(Q37757983)

22 August 2017

1 reference

title

Glucose lowering and cardiovascular disease: what do we know and what should we do? (English)

1 reference

22 August 2017

0 references

cardiovascular disease

1 reference

Alice Y Y Cheng

1

1 reference

22 August 2017

Lawrence A Leiter

series ordinal

2

1 reference

22 August 2017

publication date

1 May 2010

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

22 August 2017

published in

1 reference

22 August 2017

volume

17 Suppl 1

1 reference

22 August 2017

page(s)

S25-31

1 reference

Projecting the future diabetes population size and related costs for the U.S.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Veterans Affairs diabetes trial--corrections

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

A randomized trial of therapies for type 2 diabetes and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Intensive glycemic control in the ACCORD and ADVANCE trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

Dysglycemia, not just diabetes, is a continuous risk factor for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000368194.32356.5F

10.1097/01.HJR.0000368194.32356.5F

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference